홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
ALVO
#2379
Alvotech Ordinary Shares
3.660
0
USD
+3.68%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+3.68%
월간 변동
+3.68%
6달 변화
-56.71%
년간 변동율
-56.71%
이전 종가
3.530
0
Open
3.660
0
Bid
Ask
Low
3.660
0
High
3.660
0
양
26
마켓
주식
헬스케어
ALVO
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q4, 25
TTM
Key stats
Total common shares outstanding
301.81 M
312.02 M
1.13 B
Valuation ratios
Enterprise value
3.99 B
1.6 B
11.11 B
Price to earnings ratio
—
—
—
Price to sales ratio
—
—
—
Price to cash flow ratio
—
—
—
Price to book ratio
—
—
—
EBITDA 비율에 대한 기업 가치
—
—
—
Profitability ratios
Return on assets %
—
—
—
Return on equity %
—
—
—
Return on invested capital %
—
—
—
Gross margin %
—
—
—
Operating margin %
—
—
—
EBITDA margin %
—
—
—
Net margin %
—
—
—
Liquidity ratios
Quick ratio
—
—
—
Current ratio
—
—
—
Inventory turnover
—
—
—
Asset turnover
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
Debt to equity ratio
—
—
—
Long term debt to total assets ratio
—
—
—
Long term debt to total equity ratio
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
EBIT per share
—
—
—
EBITDA per share
—
—
—
Total debt per share
—
—
—
Cash per share
—
—
—
Net current asset value per share
—
—
—
Tangible book value per share
—
—
—
Working capital per share
—
—
—
Book value per share
—
—
—
뉴스
Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO)
Alvotech 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-03-19
Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t
알보테크 주가, 52주 최저치인 3.65달러 기록
Alvotech stock hits 52-week low at 3.65 USD
Alvotech 주식, 52주 최저치인 3.89 USD 기록
Alvotech stock hits 52-week low at 3.89 USD
Alvotech, 어려운 해 속에 52주 최저치 기록
Alvotech stock hits 52-week low at $4.31 amid challenging year
Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y
Alvotech: Why FDA Delays Don't Break The Bull Case (NASDAQ:ALVO)
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?